Your browser doesn't support javascript.
loading
The effect of sacubitril/valsartan compared to olmesartan on cardiovascular remodelling in subjects with essential hypertension: the results of a randomized, double-blind, active-controlled study.
Schmieder, Roland E; Wagner, Frank; Mayr, Michael; Delles, Christian; Ott, Christian; Keicher, Christian; Hrabak-Paar, Maja; Heye, Tobias; Aichner, Solveig; Khder, Yasser; Yates, Denise; Albrecht, Diego; Langenickel, Thomas; Freyhardt, Patrick; Janka, Rolf; Bremerich, Jens.
Afiliación
  • Schmieder RE; Department of Nephrology and Hypertension, University Hospital Erlangen, Ulmenweg 18, 91054 Erlangen, Germany.
  • Wagner F; Charité Research Organisation, Berlin, Charité Research Organisation GmbH, Charitéplatz 1, 10117 Berlin (Mitte), Germany.
  • Mayr M; Outpatient Department, University Hospital Basel, Basel, Switzerland.
  • Delles C; Institute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow, G12 8TA, UK.
  • Ott C; Department of Nephrology and Hypertension, University Hospital Erlangen, Ulmenweg 18, 91054 Erlangen, Germany.
  • Keicher C; Charité Research Organisation, Berlin, Charité Research Organisation GmbH, Charitéplatz 1, 10117 Berlin (Mitte), Germany.
  • Hrabak-Paar M; Outpatient Department, University Hospital Basel, Basel, Switzerland.
  • Heye T; University Hospital Center Zagreb, University of Zagreb School of Medicine, Kispaticeva 12 (Rebro), 10 000 Zagreb, Croatia.
  • Aichner S; Outpatient Department, University Hospital Basel, Basel, Switzerland.
  • Khder Y; Outpatient Department, University Hospital Basel, Basel, Switzerland.
  • Yates D; Novartis Pharma AG, Postfach, CH-4002 Basel, Switzerland.
  • Albrecht D; Novartis Institutes for BioMedical Research, Inc., 250 Massachusetts Avenue, Cambridge, MA 02139, USA.
  • Langenickel T; Novartis Pharma AG, Postfach, CH-4002 Basel, Switzerland.
  • Freyhardt P; Novartis Pharma AG, Postfach, CH-4002 Basel, Switzerland.
  • Janka R; Charité Research Organisation, Berlin, Charité Research Organisation GmbH, Charitéplatz 1, 10117 Berlin (Mitte), Germany.
  • Bremerich J; Department of Radiology, University Hospital Erlangen, Maximiliansplatz 1, 91054 Erlangen, Germany.
Eur Heart J ; 38(44): 3308-3317, 2017 Nov 21.
Article en En | MEDLINE | ID: mdl-29029087
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 Problema de salud: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles Asunto principal: Tetrazoles / Remodelación Ventricular / Antagonistas de Receptores de Angiotensina / Rigidez Vascular / Aminobutiratos / Imidazoles / Antihipertensivos Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Eur Heart J Año: 2017 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 Problema de salud: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles Asunto principal: Tetrazoles / Remodelación Ventricular / Antagonistas de Receptores de Angiotensina / Rigidez Vascular / Aminobutiratos / Imidazoles / Antihipertensivos Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Eur Heart J Año: 2017 Tipo del documento: Article País de afiliación: Alemania